Transparency and freedom of information releases

The commercial strategy details the actions and outcomes that will help UKHSA be a partner of choice throughout the health sector.

• From: UK Health Security Agency
• Updated: 30 April 2024

A summary of the activity of the Drug Testing on Arrest (DToA) programme since its launch in March 2022.

• From: Home Office
• Updated: 11 April 2024

• Summary: Drug Testing on Arrest (DToA) programme

  This page provides a summary of the data returns from the Drug Testing on…

• Data: Drug Testing on Arrest (DToA) programme (accessible)

  These data tables were published on 3 April 2024, presenting Drug Testing…

Agenda of the UK National Screening Committee meeting on 21 March 2024.

• From: UK National Screening Committee
• Updated: 8 April 2024

• UK NSC agenda March 2024

  1. Introduction and apologies 2. Call for new interests 3. Minutes of the…

Funding allocations for active travel schemes for local authorities in England.

• From: Active Travel England and 1 others
• Updated: 23 March 2024

NHS England's performance measured against the NHS public health functions agreement.

• From: Department of Health and Social Care
• Updated: 21 March 2024

The agenda and papers for the UK Health Security Agency (UKHSA) board meeting of 13 March 2024

• From: UK Health Security Agency
• Updated: 12 March 2024

Notes from the January 2024 meeting of the UK National Screening Committee blood spot task group.

• From: UK National Screening Committee
• Updated: 29 February 2024

This report sets out progress from the first year of the delivery of the drug strategy, from harm to hope.

• From: Home Office
• Updated: 27 February 2024

A record of interests that members of UKHSA's Advisory Board hold outside the agency.

• From: UK Health Security Agency
• Updated: 9 February 2024

List of members and their personal and non-personal interests.

• From: UK Health Security Agency
• Updated: 7 February 2024

The Advisory Committee on Malaria Prevention (ACMP) was established in 1998 to formulate guidelines on malaria prevention in the UK.

• From: UK Health Security Agency
• Updated: 7 February 2024

UK Health Security Agency's (UKHSA) annual report and accounts for the financial year 2022 to 2023, laid before Parliament on 25 January 2024.

• From: UK Health Security Agency
• Updated: 5 February 2024

The strategy will set the direction for how we will invest in and transform the use of pathogen genomics in response to infectious public health threats.

• From: UK Health Security Agency
• Updated: 24 January 2024

A register of the financial, non-financial and indirect interests of members of the UK National Screening Committee (UK NSC) and its expert groups.

• From: UK National Screening Committee
• Updated: 10 January 2024

Agenda and draft minutes of the UK National Screening Committee meeting on 10 November 2023.

• From: UK National Screening Committee
• Updated: 28 December 2023

Agenda and minutes of the UK National Screening Committee meeting held on 15 June 2023.

• From: UK National Screening Committee
• Updated: 28 December 2023

Joint annual report includes brief toxicological background to the Committees' decisions; discussion summaries; Committees' published statements.

• From: UK Health Security Agency
• Updated: 20 December 2023

Details of seminars hosted by the UK National Screening Committee.

• From: UK National Screening Committee
• Updated: 22 November 2023

This plan outlines UKHSA's main deliverables and activities for the 2023 to 2024 financial year in support of the UKHSA strategic plan and remit letter.

• From: UK Health Security Agency
• Updated: 14 November 2023

Information about how we handle potential corporate conflicts of interest (COI) between different parts of the Agency.

• From: Medicines and Healthcare products Regulatory Agency
• Updated: 3 November 2023